Therefore, we aimed at better characterizing the intrathecal and systemic immune compartment in LGI1- and CASPR2-AIE in comparison to idiopathic intracranial hypertension (IIH) and multiple sclerosis (MS) disease control patients. This evidence concerns the gene LGI1 and multiple sclerosis.